An observational study in Acute Dyspnea, sponsored by Pr. Nicolas GIRERD. Not yet recruiting at 4 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-07-22.
Sponsored by Pr. Nicolas GIRERD · Observational
This observational retrospective multi-center study focuses on patients treated for acute dyspnea by emergency medical teams. The primary objective is to identify factors associated with the risk of mortality and rehospitalization in these patients. This evaluation will be conducted both overall and within specific subgroups of interest, including gender (men/women), age categories, mode of admission, and comorbidities.
656 studies on the registry are indexed under Dyspnea; 153 are open to participants now.
This study's planned enrollment of 89,700 is above the median of 122 across 204 observational studies indexed under Dyspnea.
Browse Dyspnea studies →Pr. Nicolas GIRERD is the lead sponsor of 10 studies on the registry; 7 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Adult patients treated in the emergency department for acute dyspnea.
Exclusion Criteria:
All-cause post-hospitalization mortality and rehospitalization
Composite endpoint of all-cause post-hospitalization mortality and rehospitalization
Time frame: Within 5 years following hospital discharge
Proportion of readmissions (all-cause and specific - including hospitalization for acute dyspnea ).
Time frame: 1 month and 1 year post admission for acute dyspnea in the emergency department
Post admission mortality
Assessed by: Composite criterion of rehospitalization and/or death following emergency department admission (short and long-term). with outcome 5.
Time frame: Within 20 years following hospital discharge
Post admission rehospitalization
Assessed by: Composite criterion of rehospitalization and/or death following emergency department admission (short and long-term) with outcome with outcome 4.
Time frame: Within 20 years following hospital discharge
Erroneous etiological diagnosis of dyspnea in the emergency department
Assessed by: defined as a discrepancy between the diagnosis at discharge from the emergency department and the final diagnosis in the hospital discharge letter
Time frame: Within hospital stay, maximum 21 days
All-cause mortality and specific mortality (cardiovascular and non-cardiovascular).
Assessed by: Composite endpoint of all-cause mortality and specific mortality (cardiovascular and non-cardiovascular) with outcome 8
Time frame: Within 5 years following hospital discharge
Emergency post-admission mortality
Assessed by: Composite criterion of mortality and rehospitalization post-admission for acute dyspnea in the emergency department over the long term with outcome 9
Time frame: Within 20 years following hospital discharge
Emergency post-admission rehospitalisation
Assessed by: Composite criterion of mortality and rehospitalization post-admission for acute dyspnea in the emergency department over the long term outcome 8
Time frame: Within 20 years following hospital discharge
Duration of stay in the emergency department
Assessed by: Duration of stay in the emergency department
Time frame: Within hospital stay, maximum 21 days
Erroneous etiological diagnosis of dyspnea in the emergency department
Assessed by: Erroneous etiological diagnosis of dyspnea in the emergency department
Time frame: Within hospital stay, maximum 21 days
In-hospital mortality
Assessed by: In-hospital mortality
Time frame: Within hospital stay, maximum 21 days
Length of hospital stay
Assessed by: Length of hospital stay
Time frame: Within hospital stay, maximum 21 days
Post emergency admission (For dyspnea) mortality and rehospitalization
Assessed by: Post emergency admission (For dyspnea) mortality and rehospitalization
Time frame: Within 5 years following hospital discharge
This study is not yet recruiting, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Pr. Nicolas GIRERD